» Articles » PMID: 34445171

Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of , Zebrafish, and Models

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Aug 27
PMID 34445171
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Tauopathy refers to a group of progressive neurodegenerative diseases, including frontotemporal lobar degeneration and Alzheimer's disease, which correlate with the malfunction of microtubule-associated protein Tau (MAPT) due to abnormal hyperphosphorylation, leading to the formation of intracellular aggregates in the brain. Despite extensive efforts to understand tauopathy and develop an efficient therapy, our knowledge is still far from complete. To find a solution for this group of devastating diseases, several animal models that mimic diverse disease phenotypes of tauopathy have been developed. Rodents are the dominating tauopathy models because of their similarity to humans and established disease lines, as well as experimental approaches. However, powerful genetic animal models using , zebrafish, and have also been developed for modeling tauopathy and have contributed to understanding the pathophysiology of tauopathy. The success of these models stems from the short lifespans, versatile genetic tools, real-time in-vivo imaging, low maintenance costs, and the capability for high-throughput screening. In this review, we summarize the main findings on mechanisms of tauopathy and discuss the current tauopathy models of these non-rodent genetic animals, highlighting their key advantages and limitations in tauopathy research.

Citing Articles

Alzheimer's disease and gut-brain axis: as a model.

Alves S, Lisboa-Filho P, Zilli Vieira C, Piacenti-Silva M Front Neurosci. 2025; 19:1543826.

PMID: 39967802 PMC: 11832644. DOI: 10.3389/fnins.2025.1543826.


Promising tools into oxidative stress: A review of non-rodent model organisms.

Zhang Y, Li Y, Ren T, Duan J, Xiao P Redox Biol. 2024; 77:103402.

PMID: 39437623 PMC: 11532775. DOI: 10.1016/j.redox.2024.103402.


Tau accumulation is cleared by the induced expression of VCP via autophagy.

Giong H, Hyeon S, Lee J, Cho H, Park U, Stein T Acta Neuropathol. 2024; 148(1):46.

PMID: 39316141 PMC: 11422276. DOI: 10.1007/s00401-024-02804-z.


Choline Metabolites Reverse Differentially the Habituation Deficit and Elevated Memory of Tau Null Drosophila.

Zerva M, Triantafylloudis C, Paspaliaris V, Skoulakis E, Papanikolopoulou K Cells. 2024; 13(9.

PMID: 38727282 PMC: 11083674. DOI: 10.3390/cells13090746.


New Insights into Antioxidant Peptides: An Overview of Efficient Screening, Evaluation Models, Molecular Mechanisms, and Applications.

Zhang Y, Li Y, Quan Z, Xiao P, Duan J Antioxidants (Basel). 2024; 13(2).

PMID: 38397801 PMC: 10886007. DOI: 10.3390/antiox13020203.


References
1.
Bednarski E, Lynch G . Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J Neurochem. 1996; 67(5):1846-55. DOI: 10.1046/j.1471-4159.1996.67051846.x. View

2.
St Johnston D . The art and design of genetic screens: Drosophila melanogaster. Nat Rev Genet. 2002; 3(3):176-88. DOI: 10.1038/nrg751. View

3.
Brion J, Couck A, Passareiro E, FLAMENT-DURAND J . Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. J Submicrosc Cytol. 1985; 17(1):89-96. View

4.
Kyriakatos A, Mahmood R, Ausborn J, Porres C, Buschges A, El Manira A . Initiation of locomotion in adult zebrafish. J Neurosci. 2011; 31(23):8422-31. PMC: 6623330. DOI: 10.1523/JNEUROSCI.1012-11.2011. View

5.
Kawakami K . Transposon tools and methods in zebrafish. Dev Dyn. 2005; 234(2):244-54. DOI: 10.1002/dvdy.20516. View